MyAverix Finance
HK · Healthcare
3D Medicines Inc (1244)
Biotechnology
3D Medicines Inc (1244) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $858.26M, P/E ratio is 18.00, net margin is -49.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1244
3D Medicines Inc (1244) — FAQ
What is 3D Medicines Inc's market cap?
3D Medicines Inc (1244) has a reported market cap of $858.26M (data as of 2026-05-21).
What is 1244's P/E ratio?
The price-to-earnings (P/E) ratio for 3D Medicines Inc (1244) is 18.00 (data as of 2026-05-21).
Does 3D Medicines Inc pay a dividend?
Dividend yield is not available in the current snapshot for 3D Medicines Inc (1244). Check the MyAverix Finance app for the latest dividend data.
What sector is 3D Medicines Inc in?
3D Medicines Inc (1244) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1244 listed on?
1244 is listed on HK.
What is 3D Medicines Inc's net margin?
3D Medicines Inc (1244) reports a net margin of -49.9% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.